2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

2024

Jul 5, 2024, 03:00 | Insight
EClinicalMedicine has highlighted the SIOP Europe Annual Meeting 2024 in Milan
SIOPE shared on LinkedIn: "We are thrilled to announce that eClinicalMedicine, part of THE LANCET…
Jul 5, 2024, 02:55 | Blog
Funds generated from the Lenox Hill Hospital gala will support several of the Brain Tumor Center’s initiatives - Northwell Cancer Institute
Northwell Cancer Institute shared on Linkedin: "Funds generated from the Lenox Hill Hospital gala will…
Jul 5, 2024, 02:47 | Drugs
A new standard for treating limited-stage small cell lung cancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. David R. Spigel recently shared research on durvalumab…
Jul 5, 2024, 02:41 | Blog
Nikolas Naleid: The use of ctDNA following locoregional therapy for oligometastatic CRC
Nikolas Naleid, Internal Medicine PGY3 resident at Case Western Reserve/UH Cleveland Medical Center, shared on X:…
Jul 5, 2024, 02:38 | Blog
NCI Division of Cancer Prevention - Early Career Scientist Seminar with Dr. Venkateshwar Madka
NCI Division of Cancer Prevention shared on LinkedIn: "Join us for the next NCI Division of…
Jul 5, 2024, 02:36 | Blog
Dr. Girish Chinnaswamy has been elected Vice-Chair of the SIOP PARC Programme
International Society of Paediatric Oncology - SIOP shared on LinkedIn: "Congratulations to Dr. Girish Chinnaswamy…
Jul 5, 2024, 02:36 | Blog
Moffitt Cancer Center announces the latest Research Instructor Designations
Moffitt Cancer Center shared on X: "Moffitt is proud to announce the latest Research Instructor Designations!…
Jul 5, 2024, 02:31 | Blog
EACR at the FEBS2024 Congress
EACR shared on LinkedIn: "We showcased the EACR at the FEBS2024 Congress exhibition in Milan…
Jul 5, 2024, 02:30 | Drugs
Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma - ESMO
ESMO shared on LinkedIn: "Benefits reported for the combination of ipilimumab and nivolumab further expand…
Jul 5, 2024, 02:27 | Blog
ESMO - Ipilimumab and nivolumab in unresected advanced Hepatocellular Carcinoma
ESMO shared on X: "Benefits reported for the combination of ipilimumab and nivolumab further expand alternative…
All: 15032 Posts: 5171 - 5180
Special Coverage